Half-year report · HY
4569.TEDINET S100X24B
Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥58.7bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥130.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥55.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥1.4bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥1.5bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.6bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥13.2bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.0bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.0bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.9bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.5bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥9.1bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.3bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.5bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥1.3bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥186.0bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥193.6bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥178.9bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥49.6bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥57.3bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥136.4bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥136.3bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥130.0bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥13.0bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥15.0bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥13.0bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.0bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.0bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.9bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥6.2bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.4bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥554m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥6.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥5.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥7.6bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥4.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥2.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥26.01 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥158.17 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.86 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 73.4% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.4% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.7% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 446
| Item | Context | Value | Unit |
|---|---|---|---|
| Subsidies received inv cf | InterimDuration | 100000000 | JPY |
| Purchase of intangible assets inv cf | Prior1InterimDuration | -425000000 | JPY |
| Purchase of intangible assets inv cf | InterimDuration | -35000000 | JPY |
| Proceeds from sales and redemption of investment securities inv cf | Prior1InterimDuration | 0 | JPY |
| Proceeds from sales and redemption of investment securities inv cf | InterimDuration | 1230000000 | JPY |
| Other net inv cf | Prior1InterimDuration | -215000000 | JPY |
| Other net inv cf | InterimDuration | -102000000 | JPY |
| Net cash provided by used in investment activities | Prior1InterimDuration | -5235000000 | JPY |
| Net cash provided by used in investment activities | InterimDuration | -554000000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1InterimDuration | -10000000000 | JPY |
| Net increase decrease in short term loans payable fin cf | InterimDuration | -5300000000 | JPY |
| Proceeds from long term loans payable fin cf | Prior1InterimDuration | 14000000000 | JPY |
| Proceeds from long term loans payable fin cf | InterimDuration | － | JPY |
| Repayment of long term loans payable fin cf | Prior1InterimDuration | -100000000 | JPY |
| Repayment of long term loans payable fin cf | InterimDuration | -100000000 | JPY |
| Cash dividends paid fin cf | Prior1InterimDuration | -1855000000 | JPY |
| Cash dividends paid fin cf | InterimDuration | -2142000000 | JPY |
| Other net fin cf | Prior1InterimDuration | -57000000 | JPY |
| Other net fin cf | InterimDuration | -69000000 | JPY |
| Net cash provided by used in financing activities | Prior1InterimDuration | 1987000000 | JPY |
| Net cash provided by used in financing activities | InterimDuration | -7612000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1InterimDuration | -0 | JPY |
| Effect of exchange rate change on cash and cash equivalents | InterimDuration | － | JPY |
| Net increase decrease in cash and cash equivalents | Prior1InterimDuration | 130000000 | JPY |
| Net increase decrease in cash and cash equivalents | InterimDuration | -1979000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 13886000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 15021000000 | JPY |
| Cash and cash equivalents | Prior1InterimInstant | 14017000000 | JPY |
| Cash and cash equivalents | InterimInstant | 13042000000 | JPY |
| Provision for bonuses sga | Prior1InterimDuration | 1478000000 | JPY |
| Provision for bonuses sga | InterimDuration | 1430000000 | JPY |
| Payrolls and allowances sga | Prior1InterimDuration | 4415000000 | JPY |
| Payrolls and allowances sga | InterimDuration | 4255000000 | JPY |
| Retirement benefit expenses sga | Prior1InterimDuration | 497000000 | JPY |
| Retirement benefit expenses sga | InterimDuration | 611000000 | JPY |
| Research and development expenses sga | Prior1InterimDuration | 3844000000 | JPY |
| Research and development expenses sga | InterimDuration | 5443000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2025-11-13 | |
| Semi annual accounting period cover page | FilingDateInstant | Original text (Japanese)第68期中（自 2025年４月１日 至 2025年９月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)杏林製薬株式会社 | |
| Company name in english cover page | FilingDateInstant | KYORIN Pharmaceutical Co., Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 荻原 豊 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都千代田区大手町一丁目３番７号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)03-6374-9700（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)経理財務部長 番場 作郎 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都千代田区大手町一丁目３番７号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 03-6374-9704 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |